250 related articles for article (PubMed ID: 6029674)
1. [Hormone excretion during and after treatment with Lyndiol 2.5].
Keller M
Gynaecologia; 1967; 163(4):187-98. PubMed ID: 6029674
[No Abstract] [Full Text] [Related]
2. Evaluation of a new combination oral contraceptive: lynestrenol-mestranol (Lyndiol).
Moses LE; Goldzieher JW; Moses IG
Fertil Steril; 1969; 20(5):715-28. PubMed ID: 5822858
[No Abstract] [Full Text] [Related]
3. [Influence of various oral contraceptives on hormone secretion of the hypophysis and ovary in the sexually mature female].
Schmidt-Elmendorff H; Kaiser E
Arch Gynakol; 1971 Jun; 211(1):233-4. PubMed ID: 5108862
[No Abstract] [Full Text] [Related]
4. [Ovulation inhibitors and ACTH reserve].
Rindt W; Heinen G; Oertel GW
Endokrinologie; 1971 Apr; 57(3):358-63. PubMed ID: 4325995
[No Abstract] [Full Text] [Related]
5. Clinical evaluation of lynestrenol (Lyndiol) as an oral contraceptive agent.
Connell EB; Stone ML
J Am Med Womens Assoc; 1967 Dec; 22(12):951-5. PubMed ID: 4230214
[No Abstract] [Full Text] [Related]
6. The effect of various dosages of lynestrenol on the FSH, LH and total gonadotrophin activity during the menstrual cycle.
Schmidt-Elmendorff H
Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):368-73. PubMed ID: 5510165
[No Abstract] [Full Text] [Related]
7. [Report on practical experiences with Lyndiol and Lyndiol 2.5].
Falus M
Med Welt; 1967 Dec; 50():3089-92. PubMed ID: 5610831
[No Abstract] [Full Text] [Related]
8. [Change in calcium metabolism in women during prolonged treatment with 2,5 mg of Lyndiol].
Chef R
Bull Soc R Belge Gynecol Obstet; 1967; 37(4):255-63. PubMed ID: 5619668
[No Abstract] [Full Text] [Related]
9. [Action duration of lynestrenol as a component of an anticontraceptive agent].
Schmidt-Elmendorff H
Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):352-5. PubMed ID: 5148892
[No Abstract] [Full Text] [Related]
10. The effect of 0.5 mg lynestrenol on the follicle stimulating hormone, luteinizing hormone, oestrogen and pregnanediol excretion during the menstrual cycle.
Schmidt-Elmendorff H; Kaiser E; Kopera H
Arzneimittelforschung; 1969 Aug; 19(8):1277-9. PubMed ID: 5820293
[No Abstract] [Full Text] [Related]
11. Platelet adhesiveness, aggregation and fibrinolysis after the oral administration of the contraceptive "Lyndiol".
Farbiszewski R; Kurowska T
Thromb Diath Haemorrh; 1970 Oct; 24(1):304-7. PubMed ID: 5483970
[No Abstract] [Full Text] [Related]
12. Effects of a low-oestrogen oral contraceptive on urinary excretion of luteinizing hormone and ovarian steroids.
Elstein M; Briston PG; Jenkins M; Kirk D; Miller H
Br Med J; 1974 Jan; 1(5896):11-3. PubMed ID: 4808812
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary results of comparative trials of oral contraceptives].
Arnold M; Mall-Haefeli M; Cloeren S; Morf E; Richter RH; Roth F; Stamm H; Wyss H; Weis P
Gynaecologia; 1966; 162(5):447-52. PubMed ID: 5960452
[No Abstract] [Full Text] [Related]
14. The mechanism in inhibition of ovulation in oral contraception. 3. The excretion of total pituitary gonadotrophins and luteinizing hormone in fertile women during cyclical treatment with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone together with 17-alpha-ethynyl-oestradinol-3-methylether.
Starup J; Lebech PE
Acta Endocrinol (Copenh); 1967 Oct; 56(2):188-96. PubMed ID: 6072686
[No Abstract] [Full Text] [Related]
15. Effects of prolonged feeding of an ovulation inhibitor (Lyndiol) on ageing of the hypothalamic-ovarian axis and pituitary gland tumorigenesis in rats.
Zeilmaker GH
J Endocrinol; 1969 Jan; 43(1):xxi-xxii. PubMed ID: 5815247
[No Abstract] [Full Text] [Related]
16. Oral contraceptives and follicle-stimulating hormone.
Schmidt-Elmendorff H; Kopera H
Lancet; 1968 Jun; 1(7553):1194-5. PubMed ID: 4172299
[No Abstract] [Full Text] [Related]
17. The levels of free and conjugated 17-hydroxycorticosteroids (17-OHCS) in theplasma of users of oral contraceptives.
Pekkarinen A; Ulkkinen MO
Ann Chir Gynaecol Fenn; 1969; 58(2):105-11. PubMed ID: 5363956
[No Abstract] [Full Text] [Related]
18. A new oral contraceptive with a 7 plus 15 sequential formulation.
Brosens I; Van Assche A; Wijnants P
Arzneimittelforschung; 1970 Feb; 20(2):236-7. PubMed ID: 5467468
[No Abstract] [Full Text] [Related]
19. [Personal experiences with Anacyclin].
Vrobel T; Kovác R; Kovácová L
Cesk Gynekol; 1973 May; 38(4):234-5. PubMed ID: 4717896
[No Abstract] [Full Text] [Related]
20. Return of ovulation after discontinuance of oral contraceptives.
Rice-Wray E; Correu S; Gorodovsky J; Esquivel J; Goldzieher JW
Fertil Steril; 1967; 18(2):212-8. PubMed ID: 6020669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
